Kim E Innes1,2, Terry Kit Selfe1,2, Dharma Singh Khalsa3,4, Sahiti Kandati1. 1. Department of Epidemiology, West Virginia University School of Public Health, Morgantown, WV, USA. 2. Center for the Study of Complementary and Alternative Therapies, University of Virginia Health System, Charlottesville, VA, USA. 3. Department of Internal Medicine and Integrative Medicine, University of New Mexico School of Medicine, Albuquerque, NM, USA. 4. Alzheimer's Research and Prevention Foundation, Tucson, AZ, USA.
Abstract
BACKGROUND: While effective therapies for preventing or slowing cognitive decline in at-risk populations remain elusive, evidence suggests mind-body interventions may hold promise. OBJECTIVES: In this study, we assessed the effects of Kirtan Kriya meditation (KK) and music listening (ML) on cognitive outcomes in adults experiencing subjective cognitive decline (SCD), a strong predictor of Alzheimer's disease. METHODS:Sixty participants with SCD were randomized to a KK or ML program and asked to practice 12 minutes/day for 3 months, then at their discretion for the ensuing 3 months. At baseline, 3 months, and 6 months we measured memory and cognitive functioning [Memory Functioning Questionnaire (MFQ), Trail-making Test (TMT-A/B), and Digit-Symbol Substitution Test (DSST)]. RESULTS: The 6-month study was completed by 53 participants (88%). Participants performed an average of 93% (91% KK, 94% ML) of sessions in the first 3 months, and 71% (68% KK, 74% ML) during the 3-month, practice-optional, follow-up period. Both groups showed marked and significant improvements at 3 months in memory and cognitive performance (MFQ, DSST, TMT-A/B; p's≤0.04). At 6 months, overall gains were maintained or improved (p's≤0.006), with effect sizes ranging from medium (DSST, ML group) to large (DSST, KK group; TMT-A/B, MFQ). Changes were unrelated to treatment expectancies and did not differ by age, gender, baseline cognition scores, or other factors. CONCLUSIONS: Findings of this preliminary randomized controlled trial suggest practice of meditation or ML can significantly enhance both subjective memory function and objective cognitive performance in adults with SCD, and may offer promise for improving outcomes in this population.
RCT Entities:
BACKGROUND: While effective therapies for preventing or slowing cognitive decline in at-risk populations remain elusive, evidence suggests mind-body interventions may hold promise. OBJECTIVES: In this study, we assessed the effects of Kirtan Kriya meditation (KK) and music listening (ML) on cognitive outcomes in adults experiencing subjective cognitive decline (SCD), a strong predictor of Alzheimer's disease. METHODS: Sixty participants with SCD were randomized to a KK or ML program and asked to practice 12 minutes/day for 3 months, then at their discretion for the ensuing 3 months. At baseline, 3 months, and 6 months we measured memory and cognitive functioning [Memory Functioning Questionnaire (MFQ), Trail-making Test (TMT-A/B), and Digit-Symbol Substitution Test (DSST)]. RESULTS: The 6-month study was completed by 53 participants (88%). Participants performed an average of 93% (91% KK, 94% ML) of sessions in the first 3 months, and 71% (68% KK, 74% ML) during the 3-month, practice-optional, follow-up period. Both groups showed marked and significant improvements at 3 months in memory and cognitive performance (MFQ, DSST, TMT-A/B; p's≤0.04). At 6 months, overall gains were maintained or improved (p's≤0.006), with effect sizes ranging from medium (DSST, ML group) to large (DSST, KK group; TMT-A/B, MFQ). Changes were unrelated to treatment expectancies and did not differ by age, gender, baseline cognition scores, or other factors. CONCLUSIONS: Findings of this preliminary randomized controlled trial suggest practice of meditation or ML can significantly enhance both subjective memory function and objective cognitive performance in adults with SCD, and may offer promise for improving outcomes in this population.
Entities:
Keywords:
Alzheimer’s disease; cognitive impairment; early memory loss; memory
Authors: Carmen Martin-Ruiz; Heather O Dickinson; Barbara Keys; Elise Rowan; Rose Anne Kenny; Thomas Von Zglinicki Journal: Ann Neurol Date: 2006-08 Impact factor: 10.422
Authors: Anthony P King; Stefanie R Block; Rebecca K Sripada; Sheila Rauch; Nicholas Giardino; Todd Favorite; Michael Angstadt; Daniel Kessler; Robert Welsh; Israel Liberzon Journal: Depress Anxiety Date: 2016-04 Impact factor: 6.505
Authors: Beth E Snitz; Lisa A Weissfeld; Ann D Cohen; Oscar L Lopez; Robert D Nebes; Howard J Aizenstein; Eric McDade; Julie C Price; Chester A Mathis; William E Klunk Journal: Am J Geriatr Psychiatry Date: 2015-02-11 Impact factor: 4.105
Authors: K E Innes; T K Selfe; C J Brown; K M Rose; A Thompson-Heisterman Journal: Evid Based Complement Alternat Med Date: 2012-02-21 Impact factor: 2.629
Authors: Rebecca Erwin Wells; Catherine Kerr; Michelle L Dossett; Suzanne C Danhauer; Stephanie J Sohl; Bonnie C Sachs; Jacquelyn Walsh Feeley; Jennifer Wolkin; Robert Wall; Ted Kaptchuk; Daniel Z Press; Russell S Phillips; Gloria Y Yeh Journal: J Alzheimers Dis Date: 2019 Impact factor: 4.472
Authors: Birthe K Flo; Anna Maria Matziorinis; Stavros Skouras; Tobba Therkildsen Sudmann; Christian Gold; Stefan Koelsch Journal: PLoS One Date: 2022-06-30 Impact factor: 3.752
Authors: Kim E Innes; Terry Kit Selfe; Sahiti Kandati; Sijin Wen; Zenzi Huysmans Journal: Evid Based Complement Alternat Med Date: 2018-08-30 Impact factor: 2.629